Australia’s national medical research body advises conditional use of puberty blockers for transgender children

Australia's National Health and Medical Research Council has released new guidelines supporting the conditional use of puberty blockers for transgender children. This move challenges recent bans implemented in Queensland and the Northern Territory, sparking a national debate on gender-affirming care.
Why it matters
The guidelines represent a significant shift in medical policy that may force state governments to re-evaluate their restrictive stances on gender-affirming healthcare.
The NHMRC says trans and gender-diverse young people experience unjust and avoidable health disparities arising from stigma, discrimination and barriers to accessing health care. Photograph: Darren England/AAP The NHMRC says trans and gender-diverse young people experience unjust and avoidable health disparities arising from stigma, discrimination and barriers to accessing health care. Photograph: Darren England/AAP Health Australia’s national medical research body advises conditional use of puberty blockers for transgender children New National Health and Medical Research Council guidelines at odds with public hospital bans in Queensland and NT
Get our breaking news email , free app or daily news podcast
Prefer the Guardian on Google Australia’s largest medical research organisation has advised puberty blockers are appropriate for the gender-affirming care of children in certain circumstances, after a year-long review of international evidence.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in